DAX15.557 -0,1%ESt504.205 -0,2%MSCIW2.886 -1,7%Dow34.082 ±0,0%Nas13.278 +0,4%Bitcoin24.928 +0,1%Euro1,0663 ±0,0%Öl94,34 +1,2%Gold1.927 +0,4%
Beliebte Suche
DAX 40 Ölpreis Euro - Dollar Bitcoin - Euro Goldpreis
Meistgesucht
BASF BASF11 NVIDIA 918422 Tesla A1CX3T NEL ASA A0B733 Amazon 906866 Volkswagen (VW) vz. 766403 Bayer BAY001 Allianz 840400 Deutsche Bank 514000 Vonovia A1ML7J Mercedes-Benz Group (ex Daimler) 710000 TUI TUAG50 Apple 865985 Commerzbank CBK100 Arm A3EUCD
Alle Aktien für 0 Euro (zzgl. Spreads) handeln mit finanzen.net zero. Hier informieren
Heute im Fokus
Zinssorgen belasten: DAX verhalten -- Wall Street starten etwas stärker -- EU verhängt Millionenschwere Geldstrafe gegen Intel -- MTU, Sanofi, UBS, BASF, Allianz, Swiss Re im Fokus
Top News
Amazon-Aktie im Plus: Werbefreies Amazon Prime Video künftig nur gegen Aufschlag
Microsoft- und Activision-Aktien uneinheitlich: Britische Wettbewerbshüter offener für Microsofts Activision-Kauf
Suche...
Login

Neu auf finanzen.net?

Kostenfrei registrieren und Vorteile nutzen

Übersicht Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts
Profil

Sanofi Aktie

Kaufen
Verkaufen
Sanofi Aktien-Sparplan
101,78 EUR -0,08 EUR -0,08 %
STU
101,65 EUR -0,88 EUR -0,86 %
CHX
Aktien, ETFs, Sparpläne & Kryptos zu Top-Konditionen beim Testsieger von finanztip.de handeln!
JETZT LOSLEGEN UND GRATIS-AKTIE BEKOMMEN
Du hast schon ein Konto? Hier verknüpfen
Marktkap.130,13 Mrd. EURKGV10,97

WKN 920657

ISIN FR0000120578

Symbol SNYNF

Sanofi Aktien News

DatumMeistgelesen
EN, Sanofi-AventisPress Release: Availability of the Q3 2023 Memorandum for modelling purposes
GlobeNewswirePress Release: Availability of the Q3 2023 Memorandum for modelling purposes
EN, Sanofi-AventisPress Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change
WerbungSanofi-Aktie für 0 Euro (zzgl. Spreads) handeln bei finanzen.net zero
GlobeNewswirePress Release: Sanofi supporting vulnerable communities as part of commitment to social impact and fight against climate change
EN, Sanofi-AventisMedia Update: New data at ERS showed Xenpozyme® (olipudase alfa) improved respiratory functions in adults with ASMD
PR NewswireSanofi and rapper/actor Ice-T unveil trailer for The Season as a warning against the flu
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - August 2023
EN, Sanofi-AventisMedia Update: New data at ERS showcases Sanofi's scientific leadership in addressing unmet needs across a variety of respiratory conditions 
EN, Sanofi-AventisPress Release: Sanofi announces changes to its Executive Committee
GlobeNewswirePress Release: Sanofi announces changes to its Executive Committee
EN, Sanofi-AventisPress Release: Sanofi, Meningitis Research Foundation, and the Confederation of Meningitis Organisations ignite a global awareness initiative against meningitis with launch of The Meningitis Flag
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - July 2023
GlobeNewswirePress Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
EN, Sanofi-AventisPress Release: U.S. CDC Advisory Committee unanimously recommends routine use of Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
GlobeNewswirePress release: Online availability of Sanofi’s half-year financial report for 2023
EN, Sanofi-AventisPress release: Online availability of Sanofi’s half-year financial report for 2023
EN, Sanofi-AventisPress Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment
GlobeNewswirePress Release: Sanofi to acquire Qunol®, a fast-growing U.S. brand in the healthy aging segment
EN, Sanofi-AventisPress Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised
GlobeNewswirePress Release: Solid Q2 performance and strong pipeline momentum, Full-year 2023 business EPS guidance raised
PR NewswireSanofi Consumer Healthcare North America Earns B Corp Certification in Recognition of Environmental, Social Impact
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares – June 2023
EN, Sanofi-AventisPress Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
GlobeNewswirePress Release: FDA approves Beyfortus™ (nirsevimab-alip) to protect infants against RSV disease
EN, Sanofi-AventisPress Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease
GlobeNewswirePress Release: Vaccines R&D pipeline raises the bar in RSV, influenza, meningitis, and pneumococcal disease
EN, Sanofi-AventisPress Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody
GlobeNewswirePress Release: Positive topline Phase 2b data in atopic dermatitis support amlitelimab as a potential first and best-in-class novel investigational anti-OX40-ligand monoclonal antibody
EN, Sanofi-AventisPress Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing
GlobeNewswirePress Release: ALTUVIIIO late-breaking data at ISTH demonstrates highly effective bleed protection in children with severe hemophilia A with once-weekly dosing
EN, Sanofi-AventisPress Release: Availability of the Q2 2023 Memorandum for modelling purposes
GlobeNewswirePress Release: Availability of the Q2 2023 Memorandum for modelling purposes
GlobeNewswireSanofi: Information concerning the total number of voting rights and shares - May 2023
EN, Sanofi-AventisPress Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim
GlobeNewswirePress Release: Sanofi prevails in Zantac arbitration initiated by Boehringer Ingelheim
EN, Sanofi-AventisPress Release: Sanofi Consumer Healthcare launches new portal to unlock science and solve key challenges in self-care
EN, Sanofi-AventisPress Release: Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients
GlobeNewswirePress Release: Sanofi “all in” on artificial intelligence and data science to speed breakthroughs for patients
EN, Sanofi-AventisPress Release: FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants
GlobeNewswirePress Release: FDA Advisory Committee unanimously recommends nirsevimab as first immunization against RSV disease for all infants

Sanofi News

Sanofi News: auf dieser Seite finden Sie alle Sanofi News und Nachrichten zur Sanofi Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Sanofi News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Sanofi News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.